Fashion trends, which were popular in the nineties, are back today. That makes Dr Martens happy. In fact, sales of iconic 1460 ankle boots and 1461 shoes went up, last year, by 29%, and drove 55% of revenues. At the end of last business year (completed on last 31 March), incomes amounted to 348,6 million pounds, that is, +20% compared to the previous financial statements. As for profits, they went even better: +33%, up to 50 million pounds. The brand achieved a positive performance in all areas, especially in Europe and Middle East. The company announced that 40% of their revenues derive from items directly sold to consumers: “This channel will be a strategic priority in the next years as well”, pointed out Paul Mason, president of the brand, who carried on by saying: “Our expansion chances are outstandingly good”, also based on new stores and our website, which drove a 44 million pound turnover over the last year, therefore increasing by 35%. Dr Martens, whose brand has been controlled by Permira fund since 2014, started their manufacturing activity in Northampton, in 1960. Even though most of their boots are currently made abroad, about 70,000 pairs of boots a year are still manufactured in the plant located in the United Kingdom. Dr Martens currently runs and owns 94 stores all over the world.
Back from the past. Dr Martens is booming thanks to iconic models, as sales increased by 20%
